Harbin Pharmaceutical Group Co Ltd (600664) Habari na Bei kuhusu Hisa

Kwa nini 600664 imeongezeka kwa 2.10%?

Fahamu zaidi

600664:SHA

Harbin Pharmaceutical Group Co Ltd

CN¥ 6.32

+2.10%

(+0.13) Siku 1

16 Okt, 15:00:01 GMT +8 · CNY

Alama zote

	Alama	Bei	Tofauti	Tofauti ya asilimia

Inatayarisha maarifa maarufu ya 600664...

Fungua

CN¥ 6.26

Juu

CN¥ 6.77

Chini

CN¥ 6.19

Mtaji wa soko

15.59B

Wastani wa kiasi cha mauzo

387.14M

Kiasi cha mauzo ya hisa

412.40M

Uwiano wa bei ya hisa na mapato kwa kila hisa

31.08

Juu kwa wiki 52

CN¥ 9.86

Chini kwa wiki 52

CN¥ 2.84

EPS

CN¥ 0.20

Hisa za wawekezaji

2.54B

Idadi ya wafanyakazi

elfu 10

Fungua

CN¥ 6.26

Juu

CN¥ 6.77

Chini

CN¥ 6.19

Mtaji wa soko

15.59B

Wastani wa kiasi cha mauzo

387.14M

Kiasi cha mauzo ya hisa

412.40M

Uwiano wa bei ya hisa na mapato kwa kila hisa

31.08

Juu kwa wiki 52

CN¥ 9.86

Chini kwa wiki 52

CN¥ 2.84

EPS

CN¥ 0.20

Hisa za wawekezaji

2.54B

Idadi ya wafanyakazi

elfu 10

Hisa zinazohusiana

601288

Agricultural Bank of China Ord Shs A

CN¥ 7.24

-0.28%

601398

Industrial And Commercial Bank Of China Ord Shs A

CN¥ 8.48

-0.24%

600157

Wintime Energy Group Co Ltd

CN¥ 1.44

+0.70%

603102

Weihai Baihe Biology Thnlgcl Co Ltd

CN¥ 35.81

+0.03%

Habari

Kutoka kwenye vyanzo vya wavuti na washirika wa habari

WXXV News 25

dakika 44 zilizopita

US markets are weighed down by an extended sell-off in the tech sector

MarketWatch

saa 6 zilizopita

Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks

CNN

saa 8 zilizopita

Nasdaq sinks more than 2% as investors raise questions about AI debt

Yahoo Finance

saa 2 zilizopita

Dow (DOW) Stock Could Look Reasonable After a 43% Gain

Wasifu

Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate. The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia

Kuhusu Harbin Pharmaceutical Group Co Ltd

Afisa Mkuu Mtendaji (CEO)-

Wafanyakazielfu 10

Lilianzishwa1988

Makao makuu-

Sekta-

Tovutihayao.com

Thamani zote katika CNY	Sep 2025	Des 2025	Mac 2026	Jun 2026
Mapato	3.90B	3.94B	4.18B	4.12B
Gharama ya bidhaa zilizouzwa	2.95B	2.96B	3.17B	2.96B
Gharama ya mapato	2.95B	2.96B	3.17B	2.96B
Gharama za utafiti na maendeleo	33.63M	51.31M	27.02M	33.38M
Jumla ya gharama za utafiti na maendeleo	-	-	-	-
Gharama za uuzaji, za jumla na za usimamizi	753.48M	815.96M	721.16M	803.44M
Gharama ya uendeshaji	838.57M	897.00M	786.62M	895.87M
Jumla ya gharama za uendeshaji	3.78B	3.85B	3.96B	3.86B
Mapato ya uendeshaji	112.30M	88.76M	219.91M	264.89M
Mapato mengine yasiyo ya uendeshaji	elfu 468.22	-13.01M	-7.97M	1.21M
EBT ikijumuisha vipengee visivyo vya kawaida	119.12M	91.70M	206.43M	311.43M
EBT bila kujumuisha vipengee visivyo vya kawaida	109.94M	63.73M	208.13M	254.28M
Gharama ya kodi ya mapato	41.30M	34.62M	45.36M	63.42M
Kiwango cha kodi kinachotumika	34.67%	37.75%	21.97%	20.37%
Gharama nyingine za uendeshaji	24.67M	29.19M	21.94M	53.95M
Mapato halisi	68.89M	33.00M	161.13M	249.19M
Kiwango cha faida halisi	1.77%	0.84%	3.86%	6.05%
Mapato kwa kila hisa	-	-	-	-
Mapato ya riba na uwekezaji	4.05M	3.14M	4.20M	6.12M
Gharama ya riba	-11.05M	-10.76M	-8.01M	-10.10M
Jumla ya gharama halisi za riba	-7.00M	-7.62M	-3.81M	-3.98M
Gharama za kushuka kwa thamani na za kulipa deni	-	-	-	-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni	166.37M	143.03M	274.17M	320.66M
Faida au hasara kutokana na uuzaji wa vipengee	3.99M	-3.83M	-	-35.83M

Fedha

Uliza chochote